Skip to main content
Normal View

Medicinal Products

Dáil Éireann Debate, Tuesday - 1 February 2022

Tuesday, 1 February 2022

Questions (632, 687, 745, 747, 748, 823)

Seán Haughey

Question:

632. Deputy Seán Haughey asked the Minister for Health if he will recommend that hyperemesis medication taken by pregnant women be covered by the drug payment scheme; and if he will make a statement on the matter. [4264/22]

View answer

David Cullinane

Question:

687. Deputy David Cullinane asked the Minister for Health if either the drug xonvea or cariban will be reimbursed for pregnant women suffering nausea and hyperemesis which does not respond to conservative management; and if he will make a statement on the matter. [4516/22]

View answer

David Cullinane

Question:

745. Deputy David Cullinane asked the Minister for Health if he has considered including cariban (details supplied) on the medical card and drug payment scheme; and if he will make a statement on the matter. [4833/22]

View answer

Gary Gannon

Question:

747. Deputy Gary Gannon asked the Minister for Health the actions that are being taken to support women and pregnant persons with hyperemesis who face significant financial costs to access HSE recommended treatment of pyridoxine and doxylamine; and if he will make a statement on the matter. [4839/22]

View answer

Gary Gannon

Question:

748. Deputy Gary Gannon asked the Minister for Health if there are any licensed brands for treating hyperemesis that have an application for reimbursement on the drugs payment scheme card and the medical card; and if he will make a statement on the matter. [4840/22]

View answer

Holly Cairns

Question:

823. Deputy Holly Cairns asked the Minister for Health his views on making a medication (details supplied) for hyperemesis gravidarum to be reimbursed on the drugs payment scheme and medical card. [5171/22]

View answer

Written answers

I propose to take Questions Nos. 632, 687, 745, 747, 748 and 823 together.

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Top
Share